Envelope protein variability among HBV-infected asymptomatic carriers and immunized children with breakthrough infections

Journal of Medical Virology

Volumn 80, Issue 9, 2008, Pages 1537-1546

  Mendy, Maimuna ^a   D'Mello, Felicity ^b   Kanellos, Theophanis ^b   Oliver, Stefan ^b   Whittle, Hilton ^a   Howard, Colin R ^b  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Breakthrough infections; Hepatitis B surface mutants; Hepatocellular carcinoma

Indexed keywords

ENERGIX B; ENVELOPE PROTEIN; EPITOPE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE; VIRUS DNA; VITRONECTIN;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ARTICLE; CHILD; DNA SEQUENCE; GAMBIA; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HETEROZYGOTE; HUMAN; INFANT; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; SEROLOGY; VIRUS STRAIN;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; CARRIER STATE; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; GAMBIA; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INFANT; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PHYLOGENY; SEQUENCE ANALYSIS, DNA; VIRAL ENVELOPE PROTEINS;

HEPATITIS B VIRUS;

EID: 48249127145     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21221     Document Type: Article

References (50)

1. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. 1990. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325-329.
2. Chen WN, Oon CJ. 1999. Mutation "Hot Spot" in HLA class I-restricted T cell epitope on hepatitis B surface antigen in chronic carriers and hepatocellular carcinoma. Biochem Biophys Res Commun 262: 757-761.
3. Chen Y-CJ, Delbrook K, Dealwis C, Mimms L, Mushahwar IK, Mandecki W. 1996. Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library. Proc Natl Acad Sci USA 93:1997-2001.
4. Chen CJ, Wang LY, Yu MW. 2000. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol 15:E3-E6.
5. Chisari FV, Ferrari C. 1995. Hepatitis B Virus Immunopathogenesis. Annu Rev Immunol 13:29-60.
6. Chotard J, Inskip HM, Hall AJ, Loik F, Mendy M, Whittle H, George MO, Lowe Y. 1992. The Gambia Hepatitis Intervention Study: Follow-up of a cohort of children vaccinated against hepatitis B. J Infect Dis 166:764-768.
7. Das K, Xiong X, Yang H, Westland CE, Gibbs CS, Sarafianos SG, Arnold E. 2001. Molecular modelling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC). J Virol 75:4771-4779.
8. Fortuin M, Chotard J, Jack AD, Maine NP, Mendy M, Hall AJ, Inskip HM, George MO, Whittle HC. 1993. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation. Lancet 341:1129-1131.
9. Fortuin M, Karthigesu V, Allison L, Howard C, Hoare S, Mendy M, Whittle HC. 1994. Breakthrough infections and identification of a viral variant in Gambian children immunized with hepatitis B vaccine. J Infect Dis 169:1374-1376.
10. Hou J, Wang Z, Cheng J, Lin Y, Lau GKK, Sun J, Zhou F, Waters J, Karayiannis P, Luo K. 2001. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology 34:1027-1034.
11. Hsu HY, Chang MH, Ni YH, Lin HH, Wang SM, Chen DS. 1997. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology 26: 786-791.
12. Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL. 1999. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 30:1312-1317.
13. Huy TT, Ishikawa K, Ampofo W, Izumi T, Nakajima A, Ansah J, Tetteh JO, Nii-Trebi N, Aidoo S, Ofori-Adjei D, Sata T, Ushijima H, Abe K. 2006. Characteristics of hepatitis B virus in Ghana: Full length Genome sequences indicate the endemicity of genotype E in West Africa. J Med Virol 78:178-184.
14. Inskip HM, Hall AJ, Chotard J, Loik F, Whittle H. 1991. Hepatitis B vaccine in the Gambian Expanded Programme on Immunization: factors influencing antibody response. Int J Epidemiol 20:764-769.
15. Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC. 1999. What level of hepatitis B antibody is protective? J Infect Dis 179:489-492.
16. Kalinina T, Iwanski A, Will H, Sterneck M. 2003. Deficiency in virion secretion and decreased stability of the hepatitis B virus immune escape mutant G145R. Hepatology 38:1274-1281.
17. Karthigesu VD, Allison LM, Fortuin M, Mendy M, Whittle HC, Howard CR. 1994. A novel hepatitis B virus variant in the sera of immunized children. J Gen Virol 75:443-448.
18. Kidd-Ljunggren K, Ekdahl K, Oberg M, Kurathong S, Lolekha S. 1995. Hepatitis B virus strains in Thailand: Genomic variants in chronic carriers. J Med Virol 47:454-461.
19. Kramvis A, Restorp K, Norder H, Botha JF, Magnius LO, Kew MC. 2005. Full genome analysis of hepatitis B virus genotype E strains from South-Western Africa and Madagascar reveals low genetic variability. J Med Virol 77:47-52.
20. Lee PI, Chang LY, Lee CY, Huang LM, Chang MH. 1997. Detection of hepatitis B surface gene mutation in carrier children with or without immunoprophylaxis at birth. J Infect Dis 176:427-430.
21. Liu C-J, Kao J-H, Shau W-Y, Chen P-J, Lai M-Y, Chen D-S. 2002. Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: Correlation with viral serotypes and clinical stages of liver disease. J Med Virol 68:50-59.
22. McMahon G, Ehrlich PH, Moustafa ZA, McCarthy LA, Dottavio D, Tolpin MD, Nadler PI, Ostberg L. 1992. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology 15:757-766.
23. Mulders MN, Venard V, Njayou M, Edorh AP, Bola Oyefolu AO, Kehinde MO, Muyembe Tamfum J-J, Nebie YK, Maiga I, Ammerlaan W, Fack F, Omilabu SA, Le Faou A, Muller CP. 2004. Low genetic diversity despite hyperendemicity of hepatitis B virus genotype E throughout West Africa. J Infect Dis 190:400-408.
24. Naiman OV, Khristova ML, Byun K, Xia G, Taylor PE, Stevens CE, Margolis HS. 2002. Genetic variation of hepatitis B surface antigen coding region among infants with chronic hepatitis B virus infection. J Med Virol 68:319-327.
25. Norder H, Courouce A-M, Magnius LO. 1994. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 198:489-503.
26. Ogura Y, Kurosaki M, Asahina Y, Enomoto N, Marumo F, Sato C. 1999. Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus. J Infect Dis 180:1444-1451.
27. Oon CJ, Lim GK, Ye Z, Goh KT, Tan KL, Yo SL, Hopes E, Harrison TJ, Zuckerman AJ. 1995. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 13:699-702.
28. Oon CJ, Chen WN, Goh KT, Mesenas S, Ng HS, Chiang G, Tan C, Koh S, Teng SW, Toh I, Moh MC, Goo KS, Tan K, Leong AL, Tan GS. 2002. Molecular characterization of hepatitis B virus surface antigen mutants in Singapore patients with hepatocellular carcinoma and hepatitis B virus carriers negative for HBsAg but positive for anti-HBs and anti-HBc. J Gastroenterol Hepatol 17:S491-S496.
29. Page RD. 1996. TreeVeiw: An application to display phylogenetic trees on personal computers. Comput Appl Biosci 12:357-358.
30. Pasek M, Goto T, Gilbert W, Zink B, Schaller H, MacKay P, Leadbetter G, Murray K. 1979. Hepatitis B virus genes and their expression in E. coli. Nature 282:575-579.
31. Protzer-Knolle U, Naumann U, Bartenschlager R, Berg T, Hopf U, Meyer zum Buschenfelde KH, Neuhaus P, Gerken G. 1998. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 27:254-263.
32. Rho HM, Kim K, Hyun SW, Kim YS. 1989. The nucleotide sequence and reading frames of a mutant hepatitis B virus subtype adr. Nucleic Acids Res 17:2124.
33. Schmidt HA, Strimmer K, Vingron M, von Haeseler A. 2002. TREE-PUZZLE: Maximum likelihood phylogenetic analysis using quartets and parallel computing. Bioinformatics 18:502-504.
34. Steward MW, Partidos CD, D'Mello F, Howard CR. 1993. Specificity of antibodies reactive with hepatitis B surface antigen following immunization with synthetic peptides. Vaccine 11:1405-1414.
35. Stirk HJ, Thornton JM, Howard CR. 1992. A topological model for hepatitis B surface antigen. Intervirology 33:148-158.
36. Tai P, Banik D, Lin G, Pai S, Pai K, Lin M, Yuoh G, Che S, Hsu S, Chen T, Kuo T, Lee C, Yang C, Shih C. 1997. Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class I-restricted T-cell epitope of the surface antigen. J Virol 71:4852-4856.
37. Thanavala YM, Brown SE, Howard CR, Roitt IM, Steward MW. 1986. A surrogate hepatitis B virus antigenic epitope represented by a synthetic peptide and an internal image antiidiotype antibody. J Exp Med 164:227-236.
38. Torresi J, Earnest-Silveira L, Deliyannis G, Edgtton K, Zhuang H, Locarnini SA, Fyfe J, Sozzi T, Jackson DC. 2002. Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. Virology 293:305-313.
39. Valenzuela P, Gray P, Quiroga M, Zaldivar J, Goodman HM, Rutter WJ. 1979. Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen. Nature 280:815-819.
40. van der Sande MA, Waight PA, Mendy M, Zaman S, Kaye S, Sam O, Kahn A, Jeffries D, Akum AA, Hall AJ, Bah E, McConkey SJ, Hainaut P, Whittle HC. 2007. Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence. PLoS ONE 2:e753.
41. Vaudin M, Wolstenholme AJ, Tsiquaye KN, Zuckerman AJ, Harrison TJ. 1988. The complete nucleotide sequence of the genome of a hepatitis B virus isolated from a naturally infected chimpanzee. J Gen Virol 69:1383-1389.
42. Viviani S, Jack A, Hall AJ, Maine N, Mendy M, Montesano R, Whittle HC. 1999. Hepatitis B vaccination in infancy in The Gambia: Protection against carriage at 9 years of age. Vaccine 17:2946-2950.
43. Waters JA, Brown SE, Steward MW, Howard CR, Thomas HC. 1992. Analysis of the antigenic epitopes of hepatitis B surface antigen involved in the induction of a protective antibody response. Virus Res 22:1-12.
44. Whittle HC, Bradley AK, McLauchlan K, Ajdukiewicz AB, Howard CR, Zuckerman AJ, McGregor IA. 1983. Hepatitis B virus infection in two Gambian villages. Lancet 1:1203-1206.
45. Whittle HC, Inskip H, Hall AJ, Mendy M, Downes R, Hoare S. 1991. Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia. Lancet 337:747-750.
46. Whittle H, Jaffar S, Wansbrough M, Mendy M, Dumpis U, Collinson A, Hall A. 2002. Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children. Br Med J 325:569.
47. Wilson JN, Nokes DJ, Carman WF. 1998. Current status of HBV vaccine escape variants- a mathematical model of their epidemiology. J Viral Hepatol 5:25-30.
48. Wilson JN, Nokes DJ, Carman WF. 1999. The predicted pattern of emergence of vaccine-resistant hepatitis B: A cause for concern? Vaccine 17:973-978.
49. Yeh CT, Chang MH, Lai HY, Chang ML, Chu CM, Liaw YF. 2003. Identification of a novel pre-S2 mutation in a subgroup of chronic carriers with spontaneous clearance of hepatitis B virus surface antigen. J Gastroenterol Hepatol 18:1129-1138.
50. Zuckerman AJ. 2000. Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet 355:1382-1384.